Idexx Laboratories
(NASDAQ) IDXX
Idexx Laboratories Financials at a Glance
Market Cap
$45.65B
Revenue (TTM)
$4.30B
Net Income (TTM)
$1.06B
EPS (TTM)
$13.08
P/E Ratio
43.83
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Price
$573.10
Volume
17,857
Open
$573.39
Price
$573.10
Volume
17,857
Open
$573.39
Previous Close
$573.10
Daily Range
$570.98 - $586.27
52-Week Range
$356.14 - $769.98
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Price
$573.10
Volume
17,857
Open
$573.39
Previous Close
$573.10
Daily Range
$570.98 - $586.27
52-Week Range
$356.14 - $769.98
IDXX News
IDXX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Idexx Laboratories
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
11,000
CEO
Jonathan J. Mazelsky, MBA
Website
www.idexx.comHeadquarters
Westbrook, ME 04092, US
IDXX Financials
Key Financial Metrics (TTM)
Gross Margin
62%
Operating Margin
32%
Net Income Margin
25%
Return on Equity
66%
Return on Capital
62%
Return on Assets
32%
Earnings Yield
2.28%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$45.65B
Shares Outstanding
79.62M
Volume
17.86K
Short Interest
0.00%
Avg. Volume
504.66K
Financials (TTM)
Gross Profit
$2.66B
Operating Income
$1.36B
EBITDA
$1.47B
Operating Cash Flow
$1.18B
Capital Expenditure
$124.68M
Free Cash Flow
$1.05B
Cash & ST Invst.
$180.07M
Total Debt
$1.08B
Idexx Laboratories Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.09B
+14.3%
Gross Profit
$658.11M
+15.3%
Gross Margin
60.35%
N/A
Market Cap
$45.65B
N/A
Market Cap/Employee
$4.15M
N/A
Employees
11,000
N/A
Net Income
$248.19M
+14.8%
EBITDA
$356.22M
+19.3%
Quarterly Fundamentals
Net Cash
$897.14M
-28.4%
Accounts Receivable
$693.19M
+23.5%
Inventory
$377.76M
-1.1%
Long Term Debt
$577.14M
+5.4%
Short Term Debt
$500.07M
+13.8%
Return on Assets
31.62%
N/A
Return on Invested Capital
61.76%
N/A
Free Cash Flow
$322.59M
+44.8%
Operating Cash Flow
$352.02M
+34.3%